Lucid Diagnostics Inc. LUCD
Set alert
0.40 USD -0.03 -6.36%
At close · Oct 30
0.41 0.00 +0.35%
After hours · Oct 30, 7:44 PM ET
0.4032 Day range 0.44
0.328 52-week range 1.47
- YTD
- -62.86%
- 1 year
- -66.27%
- Open
- 0.4145
- Prev close
- 0.4323
- Mkt cap
- 77.30M
- Vol
- 1.71M
- Avg vol
- 4.90M
- EPS
- -0.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.4032
- High
- 0.44
- Forward P/E
- -1.12
- Beta
- 0.00
- Short ratio
- 0.80
- Inst. own
- 4.18%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 0.90474
- 200-d avg
- 0.87091
- 1y target
- 3.50
MAX chart
Events in this range
- Mar 25, 2024Earnings: —; estimate 0; surprise —%
- May 13, 2024Earnings: -0.21; estimate 0; surprise —%
- May 13, 2024Earnings: —; estimate 0; surprise —%
- Aug 12, 2024Earnings: —; estimate 0; surprise —%
- Aug 12, 2024Earnings: -0.2; estimate 0; surprise —%
- Aug 13, 2024Rating: Canaccord Genuity · Buy → Buy
- Sep 10, 2024Rating: Ascendiant Capital · Buy → Buy
- Nov 13, 2024Earnings: -0.2; estimate -0.16; surprise -25%
- Nov 14, 2024Rating: Needham · Buy → Buy
- Nov 14, 2024Rating: Canaccord Genuity · Buy → Buy
- Nov 15, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
- Dec 9, 2024Rating: Ascendiant Capital · Buy → Buy
Signals (87)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 7, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Dec 29, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| MACD: Sell Signal | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Apr 7, 2025 | 1 year ago |
| RSI: Overbought | Feb 10, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 20, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 23, 2024 | 1 year ago |
| SMA: Bearish | Dec 2, 2024 | 1 year ago |
| SMA: Bearish | Dec 2, 2024 | 1 year ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bearish | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Sep 30, 2024 | 2 years ago |
| SMA: Bearish | Sep 23, 2024 | 2 years ago |
| SMA: Bullish | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 8, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 3, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| RSI: Oversold | Apr 22, 2024 | 2 years ago |
| RSI: Oversold | Mar 25, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 19, 2024 | 2 years ago |
| SMA: Bearish | Feb 5, 2024 | 2 years ago |
| SMA: Bearish | Feb 5, 2024 | 2 years ago |
| SMA: Bullish | Dec 25, 2023 | 2 years ago |
| SMA: Bearish | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 27, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 27, 2023 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| MACD: Sell Signal | Sep 25, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jun 19, 2023 | 3 years ago |
| SMA: Bearish | Jun 19, 2023 | 3 years ago |
| SMA: Bullish | May 29, 2023 | 3 years ago |
| SMA: Bearish | May 22, 2023 | 3 years ago |
| SMA: Bullish | May 15, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bearish | Apr 3, 2023 | 3 years ago |
| SMA: Bearish | Mar 20, 2023 | 3 years ago |
| SMA: Bullish | Mar 13, 2023 | 3 years ago |
| SMA: Bullish | Feb 27, 2023 | 3 years ago |
| SMA: Bearish | Dec 5, 2022 | 3 years ago |
| SMA: Bearish | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | Apr 4, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
Key statistics
- Market cap
- 46.00M
- Enterprise value
- 94.79M
- Trailing P/E
- 0.00
- Forward P/E
- -1.12
- PEG ratio
- 0.00
- Price / sales
- 10.98
- Price / book
- 0.00
- EPS (TTM)
- -1.12
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 4.19M
- Revenue growth
- 49.70%
- Free cash flow
- -39.47M
- Total cash
- 14.49M
- Total debt
- 13.07M
- Return on equity
- -1007.83%
- Shares outstanding
- 59.34M
- Short % of float
- 1.74%
- 50-day average
- 0.90474
- 200-day average
- 0.87091
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 3.50 +764.6% upside
Now 0.4048
- Target (low)
- 2.00
- Target (mean)
- 3.50
- Target (high)
- 7.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy2
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 12, 2024
Expected Aug 12, 2024. Consensus EPS estimate -0.14667.
Financials — quick view
LUCD Revenue — quarterly 1.47M
LUCD Net income — quarterly -11.69M
LUCD EPS — quarterly -0.08
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.16 | -0.20 | -0.04 | -25.00% |
| Aug 12, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Aug 12, 2024 | Jun 1, 2024 | 0.00 | -0.20 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -0.21 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Mar 25, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 9, 2024 | Ascendiant Capital | main | Buy | Buy |
| Nov 15, 2024 | Cantor Fitzgerald | main | Overweight | Overweight |
| Nov 14, 2024 | Canaccord Genuity | main | Buy | Buy |
| Nov 14, 2024 | Needham | reit | Buy | Buy |
| Sep 10, 2024 | Ascendiant Capital | main | Buy | Buy |
| Aug 13, 2024 | Canaccord Genuity | main | Buy | Buy |
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- luciddx.com
News
- PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026
- Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Why RingCentral Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Lucid Diagnostics Receiving Medicare Payments For Its EsoGuard Esophageal DNA Test; Closed $15M Private Placement Of Its Newly Designated Series C Convertible Prefs To Existing Long-Term Shareholders On October 21
- Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing
Your note
Sign in to keep a note on LUCD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AKLOG LISHAN | Chief Executive Officer | Stock Award(Grant) | May 6, 2024 | 1,166,630 |
| GORDON MICHAEL ADAM | General Counsel | Stock Award(Grant) | May 6, 2024 | 400,000 |
| LAPIDUS STANLEY N | Director | Sale | Sep 25, 2023 | 101,592 |
| MCGRATH DENNIS M | Chief Financial Officer | Stock Award(Grant) | May 6, 2024 | 1,043,570 |
| O'NEIL SHAUN | President | Stock Award(Grant) | May 6, 2024 | 526,763 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Luminus Management, LLC | 1.94% | 1,152,915 | 893.62K | Sep 29, 2024 |
| Vanguard Group Inc | 0.95% | 560,915 | 434.76K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.36% | 213,540 | 165.51K | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 0.21% | 126,362 | 97.94K | Sep 29, 2024 |
| Lido Advisors, LLC | 0.17% | 100,016 | 77.52K | Sep 29, 2024 |
| Levin Capital Strategies, LP | 0.11% | 66,528 | 51.56K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.62% | 366,924 | 284.40K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.33% | 193,991 | 150.36K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.17% | 101,556 | 78.72K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.10% | 56,571 | 43.85K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.04% | 23,997 | 18.60K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.02% | 12,873 | 9.98K | Oct 30, 2024 |